Exec Chat: New CEO Of Digital Therapeutics Alliance Says Reimbursement Remains Big Issue

In an interview with Medtech Insight, Andy Molnar, new CEO of the Digital Therapeutics Alliance, outlines some of the big issues facing the digital therapeutics industry, which has seen tremendous growth during the pandemic.

Digitalcare

Developers of digital therapeutics ­– defined by the Digital Therapeutics Alliance as “evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease” – have experienced tremendous growth and investor interest during the pandemic.

The need for addressing mental health issues combined with a more relaxed US Food and Drug Administration approach that expands...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Digital Technologies

More from Medtech Insight